News
MAJI
0.0075
NaN%
--
Weekly Report: what happened at MAJI last week (0615-0619)?
Weekly Report · 3d ago
Press Release: NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth
Dow Jones · 06/17 11:03
Weekly Report: what happened at MAJI last week (0608-0612)?
Weekly Report · 06/15 09:09
MAJI: Scientific Validation And Commercial Growth Signal Breakout Potential
TipRanks · 06/10 12:30
Weekly Report: what happened at MAJI last week (0601-0605)?
Weekly Report · 06/08 09:08
Press Release: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome(TM) Commercialization
Dow Jones · 06/02 15:24
Weekly Report: what happened at MAJI last week (0525-0529)?
Weekly Report · 06/01 09:09
Weekly Report: what happened at MAJI last week (0518-0522)?
Weekly Report · 05/25 09:09
Weekly Report: what happened at MAJI last week (0511-0515)?
Weekly Report · 05/18 09:09
Weekly Report: what happened at MAJI last week (0504-0508)?
Weekly Report · 05/11 09:09
Weekly Report: what happened at MAJI last week (0427-0501)?
Weekly Report · 05/04 09:08
Weekly Report: what happened at MAJI last week (0420-0424)?
Weekly Report · 04/27 09:09
Weekly Report: what happened at MAJI last week (0413-0417)?
Weekly Report · 04/20 09:08
Weekly Report: what happened at MAJI last week (0406-0410)?
Weekly Report · 04/13 09:09
Weekly Report: what happened at MAJI last week (0330-0403)?
Weekly Report · 04/06 09:09
Weekly Report: what happened at MAJI last week (0323-0327)?
Weekly Report · 03/30 09:09
Weekly Report: what happened at MAJI last week (0316-0320)?
Weekly Report · 03/23 09:08
Weekly Report: what happened at MAJI last week (0309-0313)?
Weekly Report · 03/16 09:08
Weekly Report: what happened at MAJI last week (0302-0306)?
Weekly Report · 03/09 09:08
Weekly Report: what happened at MAJI last week (0223-0227)?
Weekly Report · 03/02 09:08
More
Webull provides a variety of real-time MAJI stock news. You can receive the latest news about Marijuana Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MAJI
Exousia Pro, Inc., formerly Marijuana, Inc., is a clinical-stage biotechnology company, which is engaged in developing new ways to use the therapeutic potential of exosomes, initially focused on oncology. The Company's mammalian exosomal technology platform has shown the capability to increase the efficacy of Merck's drug Temozolomide (TMZ) in the treatment of glioblastoma (GBM). Its patented manufacturing process utilizes plant-based materials to create exosomes used in a number of commercial applications from dermatology to dentistry. The Company's proprietary loading technology can infuse a range of molecules from drugs to deoxyribonucleic acid (DNA).